Eubiologics wins WHO prequalification for oral cholera vaccine
by BioWorld MedTech
BioWorld MedTech— South Korea’s Eubiologics Co. Ltd. said it gained the World Health Organization’s (WHO) prequalification designation on April 16 for its simplified oral cholera vaccine, approved as Euvichol-S.
CIDRAP—WHO prequalifies simplified version of oral cholera vaccine. Two facilities in South Korea are expected to begin producing the vaccine in the second quarter of the year, which is expected to help ease severe vaccine shortages.
CBS Sports—Why Cole Palmer's move from Manchester City to Chelsea was the rare win-win-win-win-win for all parties. As City and Chelsea square off in the FA Cup quarterfinals Palmer has the chance to eliminate his old team.
The Telegraph—Demand for the cholera vaccine is soaring – this company might have a solution. South Korea facility bears the international burden of mass producing oral cholera vaccines to stem an acute stockpile shortage